1-15 of 22
Quick Takes in ATTR-CM: Diagnosis Barriers
Medical Industry FeatureQuick Takes in ATTR-CM: Diagnosis Barriers
Ola Akinboboye, MD, MBH, MBA
Single-Port Robotics Improves Outcomes for Thoracic Surgery
Medical Industry FeatureSingle-Port Robotics Improves Outcomes for Thoracic Surgery
Benjamin Lee, M.D.
Jeffrey Port, M.D.
Jonathan Villena-Vargas, M.D.
Helping Patients Stay on Track With Collaborative LDL-C Care
Medical Industry FeatureHelping Patients Stay on Track With Collaborative LDL-C Care
Barry D. Bertolet MD, FACC
Todd Sandroni PharmD
Beyond the Liver: The Cardiometabolic Impact of MASLD
Medical Industry FeatureBeyond the Liver: The Cardiometabolic Impact of MASLD
Nadege Gunn, MD, CPI, DABOM, FAASLD
Uncovering Metabolic Connections: Obesity, MASLD, and Heart Disease
Medical Industry FeatureUncovering Metabolic Connections: Obesity, MASLD, and Heart Disease
Robert F. Kushner, MD
Understanding Obesity: From Adiposity to Multi-Organ Impact
Medical Industry FeatureUnderstanding Obesity: From Adiposity to Multi-Organ Impact
Robert F. Kushner, MD
- advertisement
The Patient You Might Be Missing: Severe Hypertriglyceridemia in Clinical Practice
Medical Industry FeatureThe Patient You Might Be Missing: Severe Hypertriglyceridemia in Clinical Practice
Charles Turck, PharmD, BCPS, BCCCP
Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC
LDL-C Management in Focus: A Clinical Dialogue Between Experts
Medical Industry FeatureLDL-C Management in Focus: A Clinical Dialogue Between Experts
Jaime Burkle, MD, FACC, FNLA
M. Chadi Alraies, MD, FACC, FSCAI
Aiming to Stay Lower for Longer: Exploring the Clinical Evidence for Long-term LDL-C Reduction
Medical Industry FeatureAiming to Stay Lower for Longer: Exploring the Clinical Evidence for Long-term LDL-C Reduction
Andrew Freeman, MD, FACC, FACP
Lily Dastmalchi, DO
The Risk Equation: Combining uACR and eGFR for CV Prediction
Conversations in CV Risk AssessmentThe Risk Equation: Combining uACR and eGFR for CV Prediction
Matthew Sorrentino, MD
Ashish Verma, MBBS
Albuminuria: An Overlooked Red Flag in Cardiovascular Risk
Conversations in CV Risk AssessmentAlbuminuria: An Overlooked Red Flag in Cardiovascular Risk
Matthew Sorrentino, MD
Ashish Verma, MBBS
Hidden High Risk: When BP Control Isn’t Enough in Hypertension
Conversations in CV Risk AssessmentHidden High Risk: When BP Control Isn’t Enough in Hypertension
Gates B. Colbert, MD
Michael E. Hall, MD
Clyde W. Yancy, MD
- advertisement
Under the Radar: Diagnosing Hereditary ATTR Across Specialties
Medical Industry FeatureUnder the Radar: Diagnosing Hereditary ATTR Across Specialties
Charles Turck, PharmD, BCPS, BCCCP
Kevin Alexander, MD
Anasheh Halabi, MD, PhD
Quick Takes in ATTR-CM: Symptoms and Comorbidities
Medical Industry FeatureQuick Takes in ATTR-CM: Symptoms and Comorbidities
Joshua Mitchell, MD, FACC
Elevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Conversations in CV Risk AssessmentElevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Brian P. McDonough, MD, FAAFP
Javier Morales, MD, FACP, FACE